vimarsana.com

Page 380 - Initiated Coverage News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Xcel Brands (NASDAQ:XELB) Coverage Initiated at StockNews com

StockNews.com assumed coverage on shares of Xcel Brands (NASDAQ:XELB – Free Report) in a research report released on Wednesday. The firm issued a sell rating on the textile maker’s stock. Xcel Brands Price Performance Shares of XELB opened at $1.31 on Wednesday. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.11 […]

Bayerische Motoren Werke Aktiengesellschaft (OTCMKTS:BMWYY) Receives New Coverage from Analysts at Redburn Atlantic

Redburn Atlantic assumed coverage on shares of Bayerische Motoren Werke Aktiengesellschaft (OTCMKTS:BMWYY – Free Report) in a research note published on Wednesday, Briefing.com reports. The brokerage issued a buy rating on the stock. Separately, JPMorgan Chase & Co. raised Bayerische Motoren Werke Aktiengesellschaft from a neutral rating to an overweight rating in a research note […]

Worthington Enterprises (NYSE:WOR) Receives New Coverage from Analysts at StockNews com

StockNews.com began coverage on shares of Worthington Enterprises (NYSE:WOR – Free Report) in a report issued on Wednesday morning. The firm issued a buy rating on the industrial products company’s stock. A number of other research analysts have also recently weighed in on the company. The Goldman Sachs Group assumed coverage on Worthington Enterprises in […]

Alignment Healthcare (NASDAQ:ALHC) Now Covered by Analysts at Stifel Nicolaus

Stifel Nicolaus initiated coverage on shares of Alignment Healthcare (NASDAQ:ALHC – Free Report) in a research report released on Wednesday, MarketBeat.com reports. The brokerage issued a buy rating and a $11.00 price objective on the stock. Several other research firms have also recently weighed in on ALHC. Bank of America cut shares of Alignment Healthcare […]

StockNews com Begins Coverage on Moleculin Biotech (NASDAQ:MBRX)

StockNews.com began coverage on shares of Moleculin Biotech (NASDAQ:MBRX – Free Report) in a research report released on Wednesday. The brokerage issued a sell rating on the stock. Separately, HC Wainwright reissued a buy rating and issued a $3.00 price objective on shares of Moleculin Biotech in a research note on Thursday, December 14th. Get […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.